clinical trial · NCT05001945
Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension
Hypertension, RenalMLS-101 (Part I)Placebo (Part I)Placebo (Part II)MLS-101 (Part II)
brief summary
A randomized, double-blind, placebo-controlled, dose-ranging, Phase II study to evaluate the safety, efficacy, and tolerability of MLS-101 in Subjects With Uncontrolled Hypertension
started
Jul 1, 2021
primary completion
Sep 7, 2022
completion
Oct 7, 2022
last updated
Jan 5, 2024
official title
A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Phase 2 Study to Evaluate the Safety, Efficacy, and Tolerability of MLS-101 in Subjects With Uncontrolled Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol